P175 |
Audit
on management of chronic adrenal insufficiency |
|
RK Rao, A Brahma & H Gray |
P176 |
Salivary
cortisol daycurve and quality of life assessment in optimizing
glucocorticoid replacement therapy in patients with Addison's disease |
|
LCCJ Smans, EGWM Lentjes & PMJ Zelissen |
P177 |
Symptom-specific
thresholds for testosterone deficiency modulate complaints and
metabolic risk in 434 aging male patients |
|
M Zitzmann, S Faber & E Nieschlag |
P178 |
Long-term
experience of more than 8 years with a novel formulation of testosterone
undecanoate (nebido) in substitution therapy of hypogonadal men |
|
M Zitzmann, F Saad & E Nieschlag |
P179 |
Improvements
for patients and nurses using 2.5ml prefilled syringes as the vehicle
solution for suspension of sandostatin LAR microspheres |
|
KT Maher, WM Drake, GM Besser, AB Grossman,
SL Chew, PJ Jenkins, LA Kalingag, FK Fode, MT O'Sullivan-Hawketts,
DM Walker & JP Monson |
P180 |
Impaired
thirst and AVP release in a patient with partial cranial diabetes
insipidus (CDI) and subtle pituitary disease |
|
WHMS Chandrasekara, S Khan, SS Lakra, MD
Penney & LDKE Premawardhana |
P181 |
Reactive
hypoglycaemia - can measuring insulin concentrations help understand
the pathophysiology and support diagnosis? |
|
RB Poole, AJ Brooks & JSW Li Voon Chong |
P182 |
Impaired
quality of life in patients with adrenal insufficiency - evidence
that improved glucocorticoid replacement strategies are needed |
|
S Hahner, M Loeffler, W Arlt, O Decker, AC
Koschker, D Weismann, M Fassnacht & B Allolio |
P183 |
Long-acting,
intramuscular testosterone undecanoate (TU, NEBIDO) in the treatment
of female-to-male transgender individuals |
|
JW Jaobeit, M Epe, U Hugo, M Ludwig & HM
Schulte |
P184 |
Long-acting
intramuscular testosterone undecanoate (TU, NEBIDO) in treatment
of hypogonadal aging males |
|
JW Jacobeit & HM Schulte |
P185 |
Screening
in primary care using fasting glucose uncovers significant hypoglycaemia
including an asymptomatic insulinoma |
|
S Wordsworth, M Hassanein & J Platts |
P186 |
Comparison
of the effect of sibutramine monotherapy with sibutramine-metformin
combination therapy in nondiabetic obese women |
|
M Sargin, H Sargin, H Gozu, M Tuna, F Erkal,
M Tekce & A Yayla |
P187 |
Torbay
adrenal and pituitary project |
|
S Cox |
P188 |
Autoimmune
hypoadrenalism: the profile of related conditions |
|
JAH Wass, KG White & A Elliott |
P189 |
Recombinant
hGH therapy in males with organic GHD: should we trust in total
testosterone levels for diagnosis of central hypogonadism? |
|
C Giavoli, AG Lania, E Ferrante, F Ermetici,
S Bergamaschi, CL Ronchi, B Ambrosi, A Spada & P Beck-Peccoz |
P190 |
Survey
of steroid replacement therapy |
|
S Gorick, RH Greenwood, PJ Heyburn, MJ Sampson,
KK Dhatariya & RC Temple |
P191 |
Concordance
between GH determination and IGF-I in acromegaly using two IGF-I
methods |
|
S Hepburn, SM Chambers, JA Gilbert, AM McGregor,
JP Miell & SJB Aylwin |
P192 |
Adult
Turner syndrome clinic: what are the patients' perceptions of this
specialist service? |
|
LE Smethurst |
P193 |
Adequacy
of post-glucose GH nadir <1µg/l to define biochemical
and neuroradiological remission of acromegaly |
|
CL Ronchi, V Varca, C Giavoli, E Ferrante,
A Lania, M Arosio, P Beck-Peccoz & A Spada |
P194 |
Patients
with serum prolactin >20 000mU/l - review of presentation, management
and outcome |
|
N Seevaratnam, E Khoo, R Rea & P Mansell |
P195 |
Long
term outcome in men with microprolactinoma |
|
R Rea & W Jeffcoate |
P196 |
Ophthalmic
findings in Turner syndrome |
|
B Wikiera, M Mulak, E Barg & B Reniewska |
P197 |
Early
detection of diabetic autonomic neuropathy with a new device |
|
M Fevre-Genoulaz, MJ Lafitte, SS Srikanta,
L Punitha & S Vidyanand |
P198 |
Adult
growth hormone replacement therapy after the institution of NICE
guidelines |
|
S Curran, P Lowdell, A Webb, C Holmes, M
Gurnell, DF Wood, VKK Chatterjee & HL Simpson |
P199 |
Clinical
evaluation of Sheehan syndrome |
|
A Kubat Uzum, M Mert, Y Orhan, N Ozbey & F
Aral |
P200 |
Is
a repeat or resting prolactin necessary in the investigation of
hyperprolactinaemia? |
|
R Agarwal, S Pramodh, P Durroch, S Chambers,
A McGregor & SJB Aylwin |
P201 |
Knowledge
of testosterone replacement therapy is significantly correlated
with patient satisfaction, suggesting greater need for education |
|
SV Llahana & GS Conway |
P202 |
Cushing's
disease - an audit of outcomes following pituitary surgery from
a single centre |
|
V Baskar, G Varugheese, V Carlin & RN
Clayton |
P203 |
Clinical
characterization of patients with hyperprolactinaemia due to macroprolactin |
|
F Donadio, AR Angioni, A Lania, E Orsi, P
Beck-Peccoz & A Spada |
P204 |
Total
cortisol and calculated free cortisol during the 250µg ACTH
test |
|
M Klose, M Lange, A Krogh-Rasmussen, E Haug & U
Feldt-Rasmussen |
P205 |
Comparison
of the effects of transdermal and oral oestrogen treatments on
serum and salivary cortisol concentrations |
|
A Bahri, L Breen, S Barnes, JK Powrie, SM
Thomas & PV Carroll |
P206 |
A
survey of gender dysphoria (transsexual) patients attending an
endocrine clinic |
|
G Scull, C Gibson, L Webster, DW Ray, FCW
Wu & JRE Davis |
P207 |
Osteoporosis,
osteopaenia and osteoarthritis in autoimmune hypoadrenalism |
|
JAH Wass, KG White & A Elliott |
P208 |
Autoimmune
hypoadrenalism: symptoms at diagnosis |
|
KG White, JAH Wass & A Elliott |
P209 |
Does
HT still have a place? The impact on menopausal-related symptoms |
|
C Cristea, C Vulpoi, MC Ungureanu, L Leustean,
C Concita, V Mogos & E Zbranca |
P210 |
High
mortality rate in hospital in-patients with hyponatraemia |
|
LCH Ciin, P Narayanan, F Stewart, A Heald & T
Dornan |
